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The type of vesicular transporter expressed by a neu-
ron is thought to determine its neurotransmitter phe-
notype. We show that inactivation of the vesicular in-
hibitory amino acid transporter (Viaat, VGAT) leads to
embryonic lethality, an abdominal defect known as
omphalocele, and a cleft palate. Loss of Viaat causes a
drastic reduction of neurotransmitter release in both
GABAergic and glycinergic neurons, indicating that
glycinergic neurons do not express a separate vesicu-
lar glycine transporter. This lossofGABAergic andgly-
cinergic synaptic transmission does not impair the de-
velopment of inhibitory synapses or the expression of
KCC2, the K+-Cl2 cotransporter known to be essential
for the establishment of inhibitory neurotransmission.
In the absence of Viaat, GABA-synthesizing enzymes
are partially lost from presynaptic terminals. Since
GABA and glycine compete for vesicular uptake, these
data point to a close association of Viaat with GABA-
synthesizing enzymes as a key factor in specifying
GABAergic neuronal phenotypes.
Introduction
Inhibitory neurotransmission in the adult nervous system
is chiefly mediated by release of g-aminobutyric acid
(GABA) and glycine from synaptic vesicles. GABAergic
inhibition predominates in the brain, whereas both gly-
cine and GABA act as the primary inhibitory neurotrans-
mitters in spinal cord and brainstem. To date, only a
single transporter for the filling of vesicles at both
GABAergic and glycinergic synapses has been identi-
fied. It is referred to as either vesicular GABA transporter
(VGAT) (McIntire et al., 1997) or vesicular inhibitory amino
acid transporter (Viaat) (Sagne et al., 1997). In contrast,
the glutamatergic, excitatory transmitter system em-
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4 These authors contributed equally to this work.ploys three separate vesicular glutamate transporters
with distinct expression patterns (Fremeau et al., 2004b).
The designation of Viaat as a GABA/glycine trans-
porter is based on evidence from morphological studies
showing the presence of Viaat in both GABAergic and
glycinergic synaptic terminals (Chaudhry et al., 1998),
from biochemical studies on neurotransmitter uptake
characteristics of synaptic vesicle preparations (Burger
et al., 1991; Christensen and Fonnum, 1991), and from
electrophysiological studies demonstrating corelease
of GABA and glycine from single vesicles in spinal
cord neurons (Jonas et al., 1998). However, despite the
fact that multiple lines of evidence indicate that Viaat
is a vesicular carrier for both GABA and glycine, direct
evidence is lacking, and the question as to whether Viaat
is the sole vesicular carrier responsible for all GABAergic
and glycinergic neurotransmission or whether glyciner-
gic neurons possess an additional glycine transporter
has remained unresolved. In fact, the affinity of heterol-
ogously expressed Viaat for glycine was shown to be
considerably lower than its affinity for GABA (McIntire
et al., 1997; Sagne et al., 1997). This finding is in line with
some studies on the endogenous GABA/glycine uptake
system (Bedet et al., 2000) but is contradicted by other
studies reporting lower but comparable uptake of gly-
cine versus GABA by the endogenous system (Burger
et al., 1991) or effective inhibition of GABA uptake at
low concentrations of glycine (Christensen et al., 1991).
GABA and glycine exert their well established roles as
inhibitory neurotransmitters in the mature nervous sys-
tem, where intraneuronal Cl2 concentrations are low,
and the opening of GABAA receptor (GABAAR) and gly-
cine receptor (GlyR) channels causes Cl2 influx and
membrane hyperpolarization. In immature neurons,
GABA and glycine act instead as depolarizing and even
excitatory neurotransmitters (Ben-Ari, 2002), because
intraneuronal Cl2 concentrations are high and receptor
Cl2 channel opening is followed by Cl2 efflux and mem-
brane depolarization. This depolarization caused by
GABAAR and GlyR activation is sufficient to activate volt-
age-dependent Ca2+ channels and even elicit action
potentials (Chen et al., 1996; Leinekugel et al., 1995;
Owens et al., 1996; Reichling et al., 1994; Yuste and
Katz, 1991). The relatively high intracellular Cl2 concen-
tration of immature neurons is due to the developmen-
tally early appearance of inwardly directed Cl2 trans-
porters, in particular the Na+-K+-2Cl2 cotransporter
NKCC1 (Clayton et al., 1998). The shift from the depola-
rizing to the hyperpolarizing and thereby inhibitory ac-
tion of GABA and glycine depends on the expression of
KCC2, a K+-Cl2 cotransporter that is responsible for
the Cl2 extrusion capacity of mature neurons (Rivera
et al., 1999). KCC2 transcript levels increase throughout
development in parallel with neuronal maturation (Stein
et al., 2004). Although significant KCC2 upregulation oc-
curs postnatally, its critical function in the transition to
the adult pattern of GABA/glycine hyperpolarizing action
is already apparent at birth, when KCC2 deletion mutant
mice fail to establish normal breathing patterns and die
(Hubner et al., 2001). The developmental upregulation
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576of KCC2 expression has been suggested to be an activ-
ity-dependent event, produced by the depolarizing ac-
tion of GABA and glycine in immature neurons (Ganguly
et al., 2001), a finding that was contradicted by later stud-
ies (Ludwig et al., 2003; Titz et al., 2003). Moreover, the
maturation of postsynaptic receptor clusters at glyciner-
gic contacts is also thought to be an activity-dependent
process controlled by the early depolarizing function of
glycine, because postsynaptic GlyR clustering is pre-
vented by pharmacologically blocking either GlyRs
themselves or voltage-activated Ca2+ channels (Kirsch
and Betz, 1998). Based on these and numerous other
studies, the role of GABA and glycine release in the es-
tablishment of neuronal circuits during development is
generally considered a trophic action (Ben-Ari, 2002;
Owens and Kriegstein, 2002). However, in this context
it is important to point out that GABA is also thought to
act as a trophic substance early in development before
synaptic communication is established (Represa and
Ben-Ari, 2005). Consequently, the earliest effects of
GABA on neuronal development may be due to a diffuse
mode of action mediated by nonsynaptic and nonvesic-
ular release (Demarque et al., 2002).
The generation of GABAergic synapses during devel-
opment precedes the establishment of functional gluta-
matergic inputs (Chen et al., 1995; Walton et al., 1993),
and the initially excitatory action of GABA and glycine
during development may therefore be a self-limiting pro-
cess that establishes early network activity and serves
as a mechanism to avoid excitotoxicity (Ben-Ari, 2002).
However, the roles of GABA and glycine in neuronal net-
work development may not always be equivalent, be-
cause in the brainstem and spinal cord, where both neu-
rotransmitters are used, a developmental transition from
GABAAR to GlyR-mediated responses occurs postna-
tally (Gao et al., 2001). This shift from GABAergic to gly-
cinergic neurotransmission, whose molecular basis still
remains to be resolved, does not appear to be caused
solely by postsynaptic changes in receptor composition,
since in synapses of the auditory brainstem presynaptic
changes were shown to occur (Nabekura et al., 2004).
To characterize the vesicular transporter systems of
inhibitory synapses and their role in central nervous sys-
tem development, we generated mice deficient for Viaat
and characterized their phenotype with respect to the
generation and function of GABAergic and glycinergic
synapses and the functional maturation of GABAergic
and glycinergic synaptic transmission.
Results
Viaat-Deficient Mice Die In Utero and Exhibit a Cleft
Palate and Omphalocele
We generated Viaat knockout mice (KOs) through ho-
mologous recombination in embryonic stem cells (Fig-
ures 1A–1C). Viaat KO mice die between embryonic
day (E)18.5 and birth, exhibit a hunched posture, and
at E17.5 (Figure 1D), the age chosen for experimental
analysis, and are completely immobile and stiff. Stiff-
ness is most likely a symptom of overexcitation; how-
ever, a lack of mobility was also noted at earlier embry-
onic stages (E15.5–E16.5) and is also consistent with an
absence of excitatory drive, which in the developing
nervous system is initially provided at least partially byGABA (Ben-Ari, 2002). Homozygous KO animals have
a cleft palate (Figure 1E), which was also described for
KOs of the 67 kDa isoform, but not the 65 kDa isoform,
of the main GABA-synthesizing enzymes glutamic acid
decarboxylase (GAD)67 and GAD65 (Asada et al.,
1997; Condie et al., 1997). Apparently, closure of the pal-
ate roof requires vesicular GABA release, which indi-
cates that the cleft palate in Viaat and GAD67 KOs is
due to immobility of the tongue, rather than to elimina-
tion of a trophic effect of GABA in the palate. In addition,
Viaat KOs display an omphalocele, an abdominal defect
where the intestine is not withdrawn into the abdominal
cavity during embryonic development (Figures 1D and
1E). Interestingly, this defect is also seen in embryos
deficient for KCC2 (Hubner et al., 2001), the K+-Cl2 co-
transporter responsible for extrusion of Cl2 during neu-
ronal maturation, whose expression determines the de-
velopmental shift of GABAergic and glycinergic synaptic
input from excitatory to inhibitory (Balakrishnan et al.,
2003; Rivera et al., 1999).
Because GABA is thought to have trophic effects during
neuronaldevelopment (RepresaandBen-Ari, 2005),weex-
amined Nissl-stained serial brain sections and spinal cord
sections of E17.5 Viaat KO and wild-type (wt). We found
that neither the brain nor the spinal cord of Viaat KOs
showed any morphological abnormalities (Figures 1F–1I).
These observations are in line with studies on GAD65
and GAD67 double KOs (Ji et al., 1999), where no evidence
of abnormal brain histogenesis was detectable.
The Absence of Viaat Results in Reduced GAD65/67
Levels andAltered Subcellular Distribution ofGAD67
While Viaat KO spinal cord sections showed no histolog-
ical defects, with immunofluorescence staining, a de-
creased synaptic and increased somatic labeling for
GAD67 (Figures 2A and 2B) was readily apparent in the
spinal cord of Viaat KO animals. In contrast to this, we
found no significant difference in the GAD65 staining be-
tween wt and KO spinal cord (Figures 2C and 2D). We
next looked for changes in the protein expression levels
of general synaptic markers as well as markers that are
specific for GABAergic/glycinergic synapses (Figure 3).
The only alteration detected in KO animals was a reduc-
tion of GAD65 and GAD67 levels in spinal cord, but not
whole brain (Figures 2E and 3). To confirm and quantify
the reduction of GAD65 and GAD67 levels in spinal cord,
total GAD65 and GAD67 protein levels in E17.5 whole
brain and spinal cord were measured using detection
of fluorescently labeled secondary antibodies with nor-
malization to b-tubulin levels. Total GAD65 and GAD67
protein levels in spinal cord were significantly reduced
to 65% and 64% of wt levels, respectively (Figure 2E).
However, there was no significant change of GAD pro-
tein levels in KO brain.
The most likely interpretation of these findings is that
GAD65 and GAD67 are associated with Viaat, either di-
rectly or as part of a protein complex, as has been sug-
gested for GAD65 (Jin et al., 2003). Absence of the trans-
porter leads to a reduction of protein levels of both GAD
isoforms and to mislocalization of the remaining cellular
GAD67 pool. GAD65, which unlike GAD67 is palmitoy-
lated (Kanaani et al., 2002), appears to be less depen-
dent on Viaat for synaptic targeting. Although GAD67
generally has a more cytosolic distribution than GAD65
Viaat Knockout Mice
577Figure 1. Viaat KO Mice
(A) Targeting vector and Viaat locus before
and after homologous recombination. Cod-
ing exon 1 and part of intron 1 were replaced
by a synaptobrevin 2-enhanced green fluo-
rescent protein minigene and a loxP flanked
neomycin resistance cassette (syb2-EGFP-
lox-neo-lox). The syb2-EGFP fusion protein
is not expressed in the Viaat KO mice or het-
erozygotes, not even after removal of the neo
cassette, presumably because intron 1 con-
tains transcription factor sites critical for ex-
pression from the Viaat locus. The position
of HincII restriction sites and the 50 Southern
probe are indicated. Gray arrowheads indi-
cate the position of the PCR primers used
for genotyping.
(B) Genomic Southern blot with 50 probe after
HincII digestion of stem cell DNA. Homolo-
gous recombination of the Viaat targeting
vector results in a shift of a wt 11.5 kb HincII
fragment to 8.4 kb.
(C) Genomic PCR used for genotyping Viaat
litters with 622 bp for wt and 382 bp for the
targeted locus.
(D) Viaat KO E17.5 embryo with littermate.
Note the omphalocele (arrow) of the KO pup.
(E) Hematoxylin and eosin stained sagittal
section of E17.5 Viaat KO animal with hetero-
zygous littermate for comparison. Note the
hunched posture, cleft palate (closed arrow),
and omphalocele containing the gut in the KO
animal (open arrow).
(F–I) Nissl-stained E17.5 brain and spinal cord
sections from Viaat KOs and littermate con-
trol animals. (F) Parasagittal brain sections.
Panels (G) and (H) are from coronal brain sec-
tions. (G) Cortical layering appears to be nor-
mal in Viaat KO animals. (H) Hippocampus. (I)
Spinal cord. Scale bar (F), 1 mm. Scale bar
(G–I), 100 mm.(Solimena et al., 1993), our data imply that the synaptic
GAD67 pool is directly associated with Viaat containing
synaptic vesicles. The absence of significant differences
in GAD65/67 protein levels and GAD67 localization (data
not shown) in whole brain may be attributable to the rel-
ative developmental lag in synaptogenesis in the E17.5
brain compared to spinal cord. There was no evidence
of an impairment of synapse formation in Viaat KO neu-
rons cultured from brain and spinal cord as judged by
staining with pre- and postsynaptic markers (GAD65,
synapsin, GlyR, gephyrin, GABAARb, and neuroligin 2;
Figure 6 and data not shown).
Transmitter Release from GABAergic Striatal and
Hippocampal Viaat KO Neurons Is Either Completely
Eliminated or Drastically Reduced
To examine the functional role of Viaat in inhibitory syn-
aptic transmission, we used single-neuron autaptic cul-
tures (Pyott and Rosenmund, 2002) from E17.5 Viaat KO
embryos and wt or heterozygous littermate controls. We
detected no significant differences between cultures
from wt and heterozygous animals in these and all sub-
sequent experiments, and therefore pooled the data
from both genotypes, designating them as wt in all elec-
trophysiological experiments. All electrophysiological
data are from recordings of autaptic cells. We first fo-cused on cultures from striatum, which predominantly
contain neurons that release GABA. In general, only non-
glutamatergic neurons, identified by the insensitivity of
their evoked synaptic responses to the AMPA receptor
antagonist NBQX (10 mM), were analyzed in detail. While
all NBQX-insensitive wt neurons (n = 97) showed robust
inhibitory postsynaptic currents (IPSCs) that were
blocked by the GABAAR antagonist bicuculline (10 mM),
the majority (122/210; 58%) of nonglutamatergic Viaat
KO neurons showed no detectable evoked response
(Figure 4A). The remaining 88 cells showed a drastically
reduced response amplitude (0.256 0.04 nA, compared
to 7.506 0.47 nA in wt neurons; Figure 4A).
To confirm that the residual transmission observed in
KO cells was GABAAR mediated, we examined the ef-
fects of the GABAAR and glycine receptor (GlyR) antag-
onists bicuculline and strychnine, respectively (Fig-
ure 4B). The complete inhibition of the residual current
by bicuculline, almost no inhibition at 1 mM strychnine,
and approximately 50% inhibition at 3 mM strychnine
are consistent with a purely GABA-mediated IPSC
(Jonas et al., 1998). In addition, we measured responses
to exogenously applied GABA and the glutamate recep-
tor agonist kainate to determine whether postsynaptic
receptor sensitivity was affected. No significant differ-
ences between wt and Viaat KO neurons were detected
Neuron
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GABA and glutamate.
In addition to the experiments in striatal cultures, we
also examined excitatory postsynaptic current (EPSC)
and IPSC amplitudes in hippocampal cultures. While
evoked EPSC amplitudes as well as spontaneous mini-
ature EPSC (mEPSC) amplitudes, which correspond
to the spontaneous release of single vesicles, were in-
distinguishable in wt and Viaat KO neurons (data not
shown), nonglutamatergic neurons derived from Viaat
KO mice showed again either no synaptic response
(n = 9) or very small and bicuculline-sensitive IPSC re-
sponses (n = 4). In contrast, all nonglutamatergic neu-
rons in the wt group displayed robust IPSC amplitudes.
These observations are fully consistent with the findings
in the striatal cells.
Figure 2. GAD Localization and Protein Levels
(A–D) Parasagittal sections of E17.5 ventral spinal cord. (A) GAD67
(green) shows partial colocalization with synapsin (red) in wt spinal
cord. (B) In KO spinal cord, GAD67 is mostly found in the cell somata,
with very little colocalization with synapsin. (C) GAD65 (green)
shows partial colocalization with synapsin in wt spinal cord. (D)
GAD65 staining in KO spinal cord is indistinguishable from the stain-
ing in wt samples.
(E) GAD65 and GAD67 protein levels are reduced in spinal cord but
not whole brain of Viaat KO animals. GAD protein levels of three an-
imals per genotype were analyzed with quantitative immunoblots,
and wt GAD levels set to 100% (*p < 0.05, **p < 0.01). Scale bar,
25 mM.Reduced Spontaneous Release Frequency and
Quantal Size in Viaat KO Neurons with Residual
GABA Release
To determine whether the residual GABA release in Viaat
KO neurons is vesicular, we recorded miniature IPSCs
(mIPSCs) from wt and KO cells (Figure 4D). KO cells
that were not completely silent showed a drastic reduc-
tion in the mIPSC frequency (wt: 4.18 6 0.29 Hz; KO:
0.12 6 0.032 Hz), and the amplitude of detectable
mIPSCs was reduced to 40% of wt levels (wt: 54.20 6
2.59 pA; KO: 21.81 6 1.35 pA). As for all other electro-
physiological experiments, the mean mIPSC wt values
represent pooled data from wt and heterozygous cul-
tures. Although in 2-week-old heterozygous animals the
amount of total brain Viaat protein was reduced to
45%6 5% of wt levels, comparison of mIPSC amplitudes
from cultured heterozygous and wt neurons revealed
only a slightly reduced mIPSC amplitude in the hetero-
zygous neurons, and the difference was statistically
not significant (data not shown). The percentage of KO
cells from which mIPSCs could be recorded was slightly
lower than those with detectable evoked responses
(31% versus 42%); however, this can be explained by
Figure 3. Immunoblot Analysis of E17.5 Whole Brain and Spinal
Cord
GAD65 and GAD67 levels were reduced in spinal cord, but not in
whole-brain extracts of Viaat KO mice. Note that several commercial
Viaat antibodies tested on E17.5 protein extracts gave extremely
high background staining. To demonstrate the absence of Viaat
protein in Viaat KOs, we therefore performed immunoblots on lysate
prepared form cultured neurons allowed to mature in vitro.
Viaat Knockout Mice
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Striatal Neurons
(A) IPSC amplitude distribution. The majority
of nonglutamatergic KO cells were silent,
but from 88 out of 210 KO neurons, reduced
IPSCs were recorded. (Inset) Mean amplitude
of wt and responding KO cells.
(B) Remaining relative currents (Iinhib/I) in the
presence of bicuculline (Bic.) and strychnine
(Str.) did not differ significantly between wt
and KO neurons.
(C) Exogenous application of GABA and the
glutamate receptor agonist kainate elicited
responses from KO cells that were indistin-
guishable from wt responses.
(D) mIPSC amplitude distribution. The major-
ity of KO cells were silent. However, from
31% of cells, mIPSCs of reduced amplitude
size were detected at low frequencies (inset).
(E) Median mIPSC amplitudes of individual wt
and KO neurons show a clear separation
between wt mIPSC sizes and mIPSC sizes
of KO cells with residual release.
(F) The vesicular release probability of KO
neurons was reduced compared to wt.the fact that the smaller KO mIPSCs are more likely to
escape detection than a small evoked response. Plot-
ting the median mIPSC amplitude of individual wt and
KO cells (Figure 4E) showed a clear separation between
the size of KO and wt mIPSCs, indicating that vesicles in
KO cells are not filled to wt levels. As the majority of KO
neurons were silent, and the mIPSC frequency dramati-
cally reduced in the remainder, the Viaat KO neurons
most likely release not only partially filled but mostly
empty vesicles, as has been shown to be the case for
deletion mutants of other vesicular transporters (Croft
et al., 2005; Wojcik et al., 2004). The vesicular release
probability of Viaat KO neurons with detectable evoked
IPSCs was also reduced (Figure 4F) (wt: 23% 6 1.3%;
KO: 16% 6 2%), and hence is likely to contribute to
the observed reduction in IPSC amplitude.
Since Viaat is the only vesicular transporter for GABA
described to date, the fact that vesicular GABA release
is still detectable in some KO neurons is unexpected.The combination of reduced IPSC and mIPSC size in
Viaat KO neurons is reminiscent of the reduction in EPSC
and mEPSC size, which we previously found in neurons
lacking the vesicular glutamate transporter VGLUT1
(Wojcik et al., 2004). While VGLUT2 is likely to be respon-
sible for the residual release in VGLUT1 KO neurons
(Fremeau et al., 2004a; Wojcik et al., 2004), our analysis
of Viaat KO neurons uncovers the presence of a Viaat-
independent vesicular uptake mechanism for GABA.
Transmitter Release from GABAergic/Glycinergic
Spinal Cord Neurons from Viaat KOs Is Either
Completely Eliminated or Drastically Reduced
To investigate whether the absence of Viaat also affects
vesicular glycine release, we studied spinal cord neu-
rons from E15.5 to E17.5 embryos in autaptic cultures
(Figure 5). In embryonic spinal cord, GABAAR-mediated
neurotransmission predominates, whereas GlyR-medi-
ated transmission increases dramatically after birth
Neuron
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cultures this developmental switch was partially recapit-
ulated. In young cultures (DIV8–9) most neurons were
purely GABAergic (data not shown), whereas in older
cultures (DIV12–20) most neurons displayed a mixed
GABAergic/glycinergic phenotype (Figures 5A and 5C).
Mixed IPSC amplitudes were recorded from wt and
Viaat KO spinal cord neurons. The majority of nongluta-
matergic KO cells (88/108) were silent. However, in 20
out of 108 cells we observed IPSCs, albeit with a more
than 90% reduction in amplitude (wt: 4.6 6 0.44 nA;
KO: 0.156 0.02 nA; Figure 5B). The GABAergic and gly-
cinergic components of the current were separated
based on their sensitivity to bicuculline and strychnine,
respectively (Figures 5A and 5C). Surprisingly, the rela-
tive sensitivities of the IPSCs of wt and KO neurons to
strychnine and bicuculline were indistinguishable from
Figure 5. Glycinergic/GABAergic IPSCs and mIPSCs in Spinal Cord
Neurons (DIV12–20)
(A) Raw traces of pharmacologically separated evoked GABAAR-
and GlyR-mediated currents from an autaptic spinal cord neuron.
Bicuculline (Bic.), strychnine (Str.), and both drugs together were
applied sequentially to each neuron, with intervening washout steps
of 1 min.
(B) The majority of nonglutamatergic KO spinal cord neurons
were silent. However, from 20 out of 108 cells, mixed glycinergic/
GABAergic IPSCs of a reduced amplitude were recorded.
(C) In spite of the drastic difference in the size of KO and wt spinal
cord IPSCs, their relative inhibition by bicuculline and strychnine
was identical. The remaining relative amplitude was calculated as
the ratio of the currents recorded with and without inhibitor (Iinhib/I)
and did not differ between wt and KO cells.
(D) Glycinergic mIPSCs of reduced amplitude size were recorded in
13 out of 108 KO neurons in the presence of 10 mM bicuculline.
(E) Glycinergic mIPSCs in KO cells were detected at drastically
reduced frequencies in the presence of 10 mM bicuculline.each other. In both groups, approximately 65% of the
response was mediated by glycine release (Figure 5C).
Thus, despite the drastic reduction in vesicular neuro-
transmitter content, the ratio of the remaining vesicular
GABA and glycine in the absence of Viaat was un-
changed.
Reduced Spontaneous Release Frequency and
Quantal Size in Viaat KO Neurons with Residual
Glycine Release
Given that mIPSC amplitudes in GABAergic Viaat KO
neurons are reduced (Figure 4D), we expected a similar
phenotype in glycinergic neurons. Glycinergic mIPSCs
were recorded from spinal cord neurons in the presence
of 10 mM bicuculline (Figures 5D and 5E). In KO cells that
were not completely silent, we detected glycinergic
mIPSCs at a mean frequency of 0.146 0.06 Hz, whereas
the wt glycinergic mIPSC frequency was 2.77 6 0.54 Hz
(Figure 5E). The amplitude of the detectable glycinergic
mIPSCs in KO cells was reduced to 39% of the wt ampli-
tude (wt: 30.61 6 2.39 pA; KO: 12.05 6 0.69 pA; Fig-
ure 5D), an effect that is very similar to the mIPSC ampli-
tude reduction found in GABAergic striatal neurons.
Normal Clustering of GlyR in Viaat KO Spinal
Cord Neurons
The postsynaptic clustering of GlyR has been described
as an activity-dependent process requiring the activa-
tion of the receptors themselves (Kirsch and Betz,
1998). Since the majority of Viaat KO spinal cord neurons
are silent in culture, we wanted to determine whether
GlyR clustering was affected in our cultures. We ob-
served no differences between GlyR immunoreactivity
in Viaat KO and wt confluent spinal cord cultures. GlyR
receptor puncta were directly apposed to presynaptic
terminals identified by Viaat immunoreactivity in wt neu-
rons (data not shown) and GAD65 staining in both wt
(Figures 6A–6C) and KO neurons (Figures 6D–6F). We
chose DIV20/21 autaptic spinal cord neurons to quantify
GlyR-positive synapses to avoid possible confounding
effects of competition between synapses from silent
cells and cells with residual release that might take place
in confluent cultures. The average density of autaptic
GlyR/GAD65-positive synapses in KO neurons was
2.2 6 0.2 per 10 mm2, compared to 2.1 6 0.2 per 10 mm2
in control neurons (Figure 6G). Synaptic clustering of
GlyRs therefore did not appear to be impaired in autaptic
spinal cord neurons, although 81% of neurons in the
spinal cord cultures showed no detectable evoked or
spontaneous electrophysiological activity (Figure5).How-
ever, the interpretation of these data is compromised by
the fact that neuron cell culture medium contains glycine,
and tonic and diffuse activation of GlyRs may be suffi-
cient to induce postsynaptic clustering. Since blocking
the receptors pharmacologically was shown to lead to
receptor internalization (Kirsch and Betz, 1998), we de-
cided to determine in situ whether Viaat KO animals
showed any defects in GlyR clustering. We were unable
to detect any significant punctate GlyR immunoreactivity
in either wt or KO spinal cord at E17.5. However, gephyrin
clusters, whose appearance precedes and is thought to
determine GlyR clustering in vivo and in vitro (Colin et al.,
1998; Feng et al., 1998; Kirsch et al., 1993), were readily
apparent and similarly frequent in both wt and KO spinal
Viaat Knockout Mice
581cord (Figures 6H and 6I). Gephyrin clusters in the ventral
spinal cord decorate the somata and dendrites of motor
neurons (Figures 6H and 6I).
Viaat KO Animals Show Normal KCC2 Expression
and Function
The shift from the excitatory to inhibitory action of GABA
and glycine during neuronal maturation is thought to be
Figure 6. GlyR and Gephyrin Clustering
(A–F) Spinal cord neurons from confluent cultures at DIV28. (A) Wild-
type synaptic GlyR clusters (green) apposed to GAD65 (red) positive
presynaptic terminals in DIV28 cultured spinal cord neurons. (B)
Wild-type synaptic GlyR clusters. (C) Wild-type synaptic GAD65
staining. (D) KO synaptic GlyR clusters (green) apposed to GAD65
(red) positive presynaptic terminals in DIV28 cultured spinal cord
neurons. (E) KO synaptic GlyR clusters. (F) KO synaptic GAD65
staining.
(G) Quantification of GlyR/GAD65-positive synapses in DIV20–21
autaptic spinal cord neurons.
(H and I) Transverse sections of E17.5 ventral spinal cord. (H) Wild-
type E17.5 spinal cord transverse section, ventral region, with ge-
phyrin clusters on somata and dendrites of motor neurons. (I) KO
E17.5 spinal cord transverse section, ventral region, with gephyrin
clusters decorating motor neuron somata and dendrites.
Scale bar (A–F), 10 mm; scale bar (H and I), 50 mm.an activity-dependent event that reflects the depolariza-
tion-induced upregulation of KCC2 expression. Since
the initial proposal that GABA itself is responsible for
the induction of KCC2 expression (Ganguly et al.,
2001), this mechanism of induction has been disputed
on the basis of contradictory findings (Ludwig et al.,
2003; Titz et al., 2003). The Viaat KO mice present a valu-
able tool to address this unresolved issue.
Because the Viaat and KCC2 KOs show the same ab-
dominal malformation, we hypothesized that vesicular
GABA release may indeed act upstream of KCC2 induc-
tion. However, when we determined KCC2 mRNA levels
in E17.5 whole brain and spinal cord by RNase protec-
tion assay, we found no significant changes in Viaat
KO animals (brain: 102% 6 8% of wt; spinal cord:
98% 6 15% of wt). Similarly, protein levels of KCC2
were not reduced in whole brain and spinal cord of Viaat
KO embryos (brain: 106% 6 11% of wt; spinal cord:
107% 6 8% of wt). Since a possible effect on KCC2 in-
duction is most likely to be apparent in the brain regions
that mature first and have comparatively high levels of
KCC2 protein at E17.5, we also quantified KCC2 protein
levels separately for the medulla and midbrain as well as
the hypothalamus/thalamus. We found no differences in
KCC2 levels in these regions that were statistically
significant (medulla: 125% 6 16% of wt, midbrain:
125% 6 26% of wt, hypothalamus/thalamus: 99% 6
9% of wt). To examine the possibility of locally restricted
effects on KCC2 expression, we performed immunoflu-
orescence analyses of coronal brain sections and trans-
verse spinal cord sections of E17.5 Viaat KO embryos
and littermate controls. We found the KCC2 expression
pattern in Viaat KO brain and spinal cord to be indistin-
guishable from KCC2 expression in littermate controls
(Figures 7A–7H). Hence, at least in the central nervous
system, vesicular GABA release is not necessary for in-
duction of KCC2 expression. However, one caveat to
consider is that the death of the KO mice may occur be-
fore the main upregulation of KCC2 levels takes place.
We therefore turned to the analysis of the Cl2 reversal
potential (ECl
2) in cultured striatal neurons as a measure
of KCC2 activity (Figure 8). Although the relationship be-
tween KCC2 expression levels and functional KCC2 pro-
tein may be linear only in situ and not in cultured neurons
(Khirug et al., 2005), we assumed that impaired KCC2
expression would still be reflected in the intraneuronal
Cl2 concentration at some point during maturation.
ECl
2 was determined with gramicidin perforated-patch
recordings of neurons between DIV6 and DIV14. The
concentration of intracellular Cl2 available for passage
through Cl2 channels was calculated using the Nernst
equation. Because the residual GABA release found in
some Viaat KO neurons could be sufficient for the induc-
tion of KCC2 expression, we included only silent neurons
in these analyses. ECl
2 became more negative with in-
creasing age of the neurons, as would be expected for
a decrease in the intracellular Cl2 concentration during
maturation, with no detectable difference between wt
and KO neurons (Figures 8B–8D). Furthermore, no signif-
icant changes of KCC2 protein levels were detected in
Viaat KO striatal cultures (KCC2 protein: 116% 6 10%
of wt), demonstrating that neither KCC2 induction nor
KCC2 function are impeded in the absence of Viaat. To
exclude the possibility that tonic activation of GlyRs
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Red immunofluorescent labeling represents KCC2 staining: the Map2 antibody (green) was used as a counterstain. Grayscale images on the right
show KCC2 labeling alone. (A) Spinal cord, ventral horn. Note the KCC2 labeling in cell bodies and processes. (B) Septum. (C) Hippocampus and
cortex. (D) Thalamus. (E) Cortexand globus pallidus. (F) Cortex. (G) Hippocampus. (H) Hippocampus, CA1.Note theKCC2 labelingoutlining individual
cell bodies and processes. v. horn, ventral horn; sept, septum; cort, cortex; hip, hippocampus; thal, thalamus; gp, globus pallidus. Scale bar, 100 mm.through glycine present in the cell culture medium in-
duces expression of KCC2, we also compared the intra-
cellular Cl2 concentration and KCC2 protein levels of
wt and KO neurons raised in the presence of 1mM strych-
nine, but found no significant differences (data not
shown).Discussion
Corelease and Viaat-Independent Release of GABA
and Glycine
The present study on Viaat-deficient mice provides di-
rect evidence for vesicular corelease of GABA and
Viaat Knockout Mice
583glycine from spinal cord neurons and shows that this
corelease is due to the fact that GABA and glycine are
sequestered into synaptic vesicles by the same trans-
porter protein, Viaat. However, our analyses also indi-
cate that at least one other transporter or transport
mechanism is able to import GABA and glycine into syn-
aptic vesicles, because some Viaat-deficient neurons
Figure 8. Gramicidin Perforated-Patch Recordings in Cultured
Striatal Neurons
(A) Raw traces of the current in presence and absence of 5 mM GABA
during voltage ramps from 280 mV to +20 mV. Voltage ramps were
repeated three times and the chloride reversal potential (ECl2) deter-
mined. Only those cells where ECl2 remained stable (65 mV) were
included in the analysis, and the concentration of intracellular Cl2
([Cl2]i) available for passage through Cl
2 channels was calculated
using the Nernst equation.
(B) ECl2 decreases with the maturation of the neurons in both wt and
KO cultures.
(C) Cumulative representation of the ECl2 determined for all cells re-
corded between DIV6 and DIV14. (Inset) Mean ECl2 values do not dif-
fer between wt and KO cells.
(D) Cumulative representation of the internal Cl2 concentration
([Cl2]i) calculated for all cells. (Inset) Mean [Cl
2]i values of wt and
KO values show no significant difference.still show measurable vesicular release of the two trans-
mitters (Figures 4 and 5). The unchanged vesicular
GABA/glycine ratio in Viaat KO spinal cord neurons indi-
cates that a candidate transporter or transport mecha-
nism should have a Viaat-like substrate specificity, but
current databases contain no evidence of a transporter
with high sequence homology to Viaat. Since half of
the striatal and most spinal cord neurons of Viaat KO
mice were silent (Figures 4 and 5), this putative trans-
porter should be present only in a subset of neurons.
Furthermore, because quantal size was reduced in Viaat
KO cells, but not in heterozygous cells, this second
GABA/glycine transporter would have to be either less
efficient or present in a significantly lower copy number
than Viaat. However, because the residual release de-
tected in Viaat KO cells is minimal, the putative carrier
is unlikely to represent a bona fide vesicular GABA/gly-
cine transporter, and three alternative explanations
might be considered. First, in the absence of Viaat,
GABA and glycine may accumulate in the cytosol of
the terminal and therefore be taken up by one or more
vesicular transporters whose main cargo is usually an-
other substrate. Second, minimal vesicular GABA and
glycine uptake may occur via a transporter-independent
mechanism, for instance during endocytosis. Third, the
observed residual currents may be due to gating of
GABAARs and GlyRs by other amino acids, such as
b-alanine or taurine. We consider the latter scenario to
be the least likely because of the low affinity of these
amino acids for GABAARs and GlyRs (Jonas et al., 1998).
Definition of GABAergic and Glycinergic
Neuronal Phenotypes
Our data show that the specification of GABAergic
and glycinergic neurons is more complex and mecha-
nistically distinct from that of the glutamatergic pheno-
type, where the presence of the VGLUTs alone is the
determining factor (Bellocchio et al., 2000; Takamori
et al., 2000). Since Viaat is the major vesicular trans-
porter for both GABA and glycine, the development of
a GABAergic versus a glycinergic phenotype is critically
dependent on the relative levels of GABA and glycine
available for vesicular uptake. A purely glycinergic phe-
notype should develop in the absence of GAD65/67, and
in the presence of Viaat and the neuronal plasma mem-
brane glycine transporter Glyt2, whose expression levels
regulate quantal size at glycinergic synapses (Gomeza
et al., 2003). However, genetic deletion of Glyt2 only re-
duces quantal glycine release and does not eliminate it
(Gomeza et al., 2003), indicating that in mouse spinal
cord intracellular glycine levels are sufficient for limited
uptake by Viaat even in the absence of Glyt2. Although
this may not be the case for all GABAergic cell types
(Kalloniatis et al., 1996), the question arises as to how
a purely GABAergic phenotype is determined. The ex-
pression of GAD65/67 and plasma membrane GABA
transporters (GAT-1/2/3/4) alone would not suffice as
a determinant of a pure GABAergic phenotype in neu-
rons where glycine levels are sufficiently high for uptake
by Viaat and would therefore be expected to result in
mostly mixed-release terminals. Here, the close associ-
ation of Viaat and GAD65 as well as GAD67 (Figure 2) ap-
pears to be essential to favor GABA uptake and thereby
shift the balance toward the GABAergic phenotype.
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release would then be achieved through downregulation
of GAD65/67. This type of negative correlation between
GAD65/67 expression and the development of a glyci-
nergic phenotype has been demonstrated for synapses
of the auditory brainstem (Nabekura et al., 2004). Inter-
estingly, the percentage of mixed GABA/glycine release
has been reported to remain relatively constant during
perinatal spinal cord development (Gao et al., 2001).
This mixed GABAergic/glycinergic phenotype, which is
predicted to result from limited expression of GAD65/
67 and plasma membrane GABA transporters, is likely
be of functional relevance because corelease of GABA
and glycine can provide an autoregulatory feedback
mechanism through activation of presynaptic GABABR
(Lim et al., 2000), which would not be available for gly-
cine release alone.
Gephyrin and GlyR Clustering in Viaat KO Neurons
In cultured immature spinal cord neurons, the postsyn-
aptic clustering of gephyrin and the subsequent accu-
mulation of GlyRs in these clusters has been shown to
require GlyR activation, concomitant membrane depo-
larization, gating of voltage-dependent Ca2+ channels,
and Ca2+ influx (Kirsch and Betz, 1998). However, in
the Viaat KO mice, we found no evidence that gephyrin
clustering on motor neurons in the ventral horn of the
spinal cord was impaired (Figure 6), indicating that ge-
phyrin clusters form even in the absence of GABA or gly-
cine release. Unfortunately, the majority of gephyrin
clusters in spinal cord at E17.5 does not yet correspond
to mature glycinergic synapses, since we were not able
to detect significant punctate GlyR immunoreactivity.
This finding is consistent with a study showing that in
newborn rat spinal cord the number of gephyrin clusters
exceeds that of GlyR clusters, and a 1:1 correspon-
dence is not achieved until postnatal day 10 (Colin
et al., 1998).
Since the Viaat KO mice die between E18.5 and birth,
we were unable to investigate the full maturation of gly-
cinergic synapses in situ. In our spinal cord cultures,
about 80% of neurons were silent, and the remainder
showed dramatically reduced activity, yet we detected
no difference in the density of GlyR-positive synapses
between Viaat KO and wt neurons. This finding demon-
strates that synaptic GlyR clustering does not require
synaptic release of glycine, but we cannot exclude that
the glycine present in the culture medium contributes to
the maturation of glycinergic synapses in cultured spinal
cord neurons, for example by inducing ectopic GlyR
clusters that are subsequently recruited to synapses.
GABA/Glycine Release and KCC2 Expression
In addition to the maturation of postsynaptic specializa-
tions at glycinergic synapses, the developmental upre-
gulation of KCC2 expression is a second developmental
process for which a requirement for the depolarizing ac-
tion of GABA and glycine has been described. In this
context, different studies on cultured neurons came to
different conclusion as to whether GABAAR activation
is required for KCC2 induction (Ganguly et al., 2001) or
whether this process proceeds even if GABAAR and
GlyR are blocked pharmacologically (Ludwig et al.,
2003; Titz et al., 2003).At first glance, the presence of an omphalocele in Vi-
aat and KCC2 KO mice (Hubner et al., 2001), a phenotype
which is also caused by mutations affecting Pitx2 (Katz
et al., 2004), a transcription factor with recognition sites
in the Viaat promoter (Ebihara et al., 2003), is suggestive
of a functional link between vesicular GABA/glycine re-
lease and KCC2 activity. However, we were unable to
establish a causal link between vesicular GABA/glycine
release and KCC2 expression in the brain or the Cl2
equilibrium potential ECl2 and, by inference, KCC2 func-
tion, in our autaptic cell culture system. Although GABA
released via nonvesicular mechanisms (Demarque et al.,
2002) could potentially still mediate the induction of
KCC2 expression in Viaat KO embryos, our data indicate
that KCC2 expression is not regulated by GABA or gly-
cine-mediated membrane depolarization. A scenario
that nonetheless assumes a functional link as the reason
for the shared phenotype is that the inhibitory action of
GABA/glycine release may be necessary for the proper
withdrawal of the embryonic gut during development,
a requirement that could not be met in the absence of
either Viaat or KCC2. The fact that GAD65/67 double
KOs do not show the same defect (Ji et al., 1999) might
argue against this explanation, but GAD-independent
GABA synthesis pathways are known to exist (Seiler,
1980) and could provide limited GABA levels in the ab-
sence of GAD65/67. Alternatively, GABA/glycine release
might upregulate KCC2 expression in a gut-specific,
locally restricted manner, as is seen in turtle retina
(Leitch et al., 2005), or Viaat and KCC2 might act in par-
allel pathways during gut development, involving pro-
cesses that are not related to GABA/glycine release or
Cl2 transport. However, KCC2 expression in embryonic
gut or umbilical cord has not been demonstrated (Hub-
ner et al., 2004) and is therefore likely to be rather low
or restricted to an extremely small population of cells.
Conclusion
Our analysis demonstrates that Viaat is the main vesicu-
lar transporter for both GABA and glycine and thus ex-
plains how neurons in the mammalian central nervous
system achieve corelease of these two transmitters.
Apart from Viaat, neurons in the central nervous system
appear to contain an as yet unknown vesicular transport
system for GABA and glycine with Viaat-like substrate
specificity. This transport system is responsible for the
residual GABA and glycine release activity of Viaat KO
neurons.
Our analyses uncovered no evidence for a role of
GABA as a trophic substance. Both major developmen-
tal defects seen in Viaat KOs, failures in gut withdrawal
and palate closure, can be understood as defects sec-
ondary to loss of GABA/glycine-mediated neurotrans-
mission and complete paralysis. Furthermore, in con-
trast to current hypotheses, synaptogenesis and the
functional maturation of GABAergic and glycinergic
neurons were not impaired in Viaat KOs. Most notably,
the formation of glycinergic postsynaptic specializa-
tions and the developmental induction of KCC2 expres-
sion, both processes that are thought to be dependent
upon synaptic glycinergic and GABAergic activity,
were normal in Viaat KOs despite an almost complete
shutdown of GABAergic and glycinergic synaptic trans-
mission.
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E18.5 and birth, which prevented us from analyzing the
maturation of the GABAergic and glycinergic transmitter
systems in later phases of development. Future analy-
ses of the full spectrum of effects controlled by vesicular
GABA and glycine release in the maturing nervous sys-
tem will require the generation of conditional Viaat KO
mice.
Experimental Procedures
Generation of Viaat KO Mice
The coding region of the Viaat gene between the start codon and
an XbaI site in the first intron was replaced with a synaptobrevin 2-en-
hanced green fluorescence protein (syb2-EGFP) minigene followed
by a loxP flanked neomycin resistance (neo) cassette through homol-
ogous recombination in embryonic stem cells (129/ola). Genomic re-
gions used in construction of the targeting vector were identified
through screening of a lambda fixII 129/Sv phage library (Stratagene).
In addition to the 5 kb 50 arm, the 2.4 kb 30 arm, and the 2.5 kb syb2-
EGFP-neo cassette, two thymidine kinase gene cassettes for nega-
tive selection were included in the targeting vector (Figure 1A). The
syb2-EGFP fusion protein is not expressed in the Viaat KO mice,
not even after cre-mediated removal of the neo cassette. Control an-
imals were wild-type or heterozygous littermates of Viaat KO mice.
Animal care was in accordance with the institutional guidelines.
Protein Analysis
Protein levels in mouse E17.5 brain and spinal cord homogenate as
well as lysate prepared from cultured neurons were assessed by
immunoblotting using the following primary antibodies: rabbit-anti-
GAD65 (AB5082), mouse-anti-GAD67 (MAB5406), rabbit-anti-
VGAT, rabbit-anti-GABAARa1, guinea-pig-anti-VGLUT2 (all from
Chemicon), mouse-anti-synapsin1, mouse-anti-GlyR(C.4a), mouse-
anti-Rab3 (all from Synaptic Systems), mouse-anti-gephyrin,
mouse-anti-Rim1/2 (both from BD Transduction Laboratories),
mouse-anti-b-Tubulin (Sigma), rabbit-anti-neuroligin 2 (Varoqueaux
et al., 2004), and rabbit-anti-KCC2 (raised against the C terminus).
Peroxidase-coupled secondary antibodies to mouse and rabbit
IgG (Jackson ImmunoResearch) and guinea-pig IgG (Acris) were
used, followed by visualization through enhanced chemilumines-
cence (Amersham Pharmacia Biotech). Protein levels of GAD65,
GAD67, and KCC2 were quantified using detection of fluorescently
labeled secondary antibodies (IRDye 800, Odyssey) with an Odyssey
infrared scanner (LI-COR Biotechnology). Expression levels were
normalized to b-tubulin levels, and values are expressed as mean 6
standard error. Significance was assessed using Student’s t test.
RNA Analysis
Total RNA from E17.5 brain and spinal cord was prepared with Trizol
reagent (Invitrogen).
KCC2 RNA levels of E17.5 brain and spinal cord were quantified by
RNase protection assay (RPA) using the RPA III kit (Ambion) in com-
bination with chemiluminescence detection (Pierce). The KCC2
probe was amplified from a mouse brain cDNA library (Clontech)
using the primers 50-GCTGGTGCTGGTGCGTGTGGAC-30 and 50-CG
AGGTGGCCGGCTGTAGTTTC-30. KCC2 RNA levels were normal-
ized to cyclophilin mRNA levels. Values are expressed as mean 6
standard error.
Morphological Analysis
Brain and spinal cord samples were immersion fixed (4% parafor-
maldehyde) and either cryoprotected (30% sucrose) and frozen or
dehydrated and embedded in paraffin. For morphological compari-
son, frozen brain sections and paraffin-embedded spinal cord sec-
tions were stained with thionin and cresyl violet, respectively. For
immunofluorescence analysis, frozen sections were stained using
mouse-anti-GAD67 (MAB5406) and mouse-anti-GAD65 (MAB351R)
antibodies (Chemicon) and rabbit-anti-synapsin antiserum (Synap-
tic Systems). To assess the distribution of KCC2 expression, rab-
bit-anti-KCC2 (raised against the C terminus) was used together
with mouse-anti-Map2 (MAB3418, Chemicon). The incubation with
primary antibodies was followed by detection with IgG-coupledAlexa Fluor 488 and Alexa Fluor 555 dyes, respectively (Molecular
Probes). For immunodetection of gephyrin in E17.5 spinal cord
with mouse-anti-gephyrin (Synaptic Systems), the spinal cord
sections were boiled in 0.01 M citrate buffer (pH 6) prior to incubation
with the antibody. Cultured neurons were stained with mouse-anti-
GlyR(C.4a) (Synaptic Systems) and rabbit-anti-GAD65 (AB5082),
followed by detection with IgG-coupled Alexa Fluor 488 and Alexa
Fluor 633, respectively. False-color images were obtained with
a conventional epifluorescence microscope (Olympus BX61).
Quantification of Synaptic GlyR Clustering
For quantification of GlyR-positive synapses, autaptic spinal cord
neurons stained with mouse-anti-GlyR(C.4a) (Synaptic Systems)
and rabbit-anti-GAD65 (AB5082) were photographed (Olympus
BX61) and the images analyzed using analySISB (Olympus) software.
Primary and secondary dendrites were outlined, and GlyR/GAD65-
positive synapses were counted. Values are expressed as mean
number of synapses per 10 mm2 6 standard error.
Electrophysiology and Cell Culture
Microisland cultures of E17.5 striatal and hippocampal neurons and
E15.5 to E17.5 spinal cord neurons were prepared according to pub-
lished procedures (Pyott and Rosenmund, 2002). Experiments were
performed using neuron cultures between DIV6 and 20. All extracel-
lular solutions were applied with a custom-built fast flow system con-
sisting of an array of flow pipes controlled by a stepper motor that
allows complete and rapid solution exchange with time constants
of approximately 30 ms (Pyott and Rosenmund, 2002; Rosenmund
et al., 1995). Nonglutamatergic cells were identified by the insensitivity
of their evoked synaptic response to the AMPA and kainate receptor
antagonist NBQX (1,2,3,4-Tetrahydro-6-nitro-2,3-dioxo-benzo[f]qui-
noxaline-7-sulfonamide, 10 mM). To distinguish between GABAergic
and glycinergic IPSCs, the respective antagonists bicuculline and
strychnine (bicuculline 10 mM and strychnine at 1 mM and 3 mM)
were used. No tonic currents were detected during the application
of bicuculline or strychnine in striatal or spinal cord cultures. Com-
parison of the effects of 1 mM strychnine, 3 mM strychnine, and
10 mM bicuculline was performed in striatal neurons. IPSCs were re-
corded sequentially during the application of bicuculline and strych-
nine as well as in the presence of both antagonists; the intervening
wash steps with bath solution lasted 1 min. Postsynaptic GABA
and AMPA receptor sensitivity was tested with the application of
GABA at 3 mM or 10 mM, and 10 mM kainate, respectively. Recordings
of mIPSCs were done in the presence of 300 nM tetrodotoxin, and for
detection of glycinergic mIPSCs 10 mM bicuculline was applied.
Gramicidin perforated-patch-clamp recordings were performed as
described (Rhee et al., 1994), with 10 mg/ml gramicidin in the pipette
solution. Vesicular release probability was measured as the ratio be-
tween IPSC charge and the size of the vesicle pool released in re-
sponse to application of hypertonic sucrose solution (Pyott and
Rosenmund, 2002), and statistical significance was assessed by un-
paired Kolmogorov-Smirnov comparison. Data acquisition and anal-
yses were done as previously described (Pyott and Rosenmund,
2002), with values expressed as mean 6 standard error.
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